Cormorant Asset Management, LP - EIDOS THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Cormorant Asset Management, LP ownership history of EIDOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$50,186,000
-0.2%
993,185
-5.9%
1.93%
+0.6%
Q2 2020$50,306,000
-6.6%
1,055,302
-4.1%
1.92%
-23.4%
Q1 2020$53,889,000
+89.4%
1,100,000
+121.9%
2.50%
+120.6%
Q4 2019$28,448,000
+46.3%
495,692
-8.3%
1.14%
-4.1%
Q3 2019$19,448,000
+13.4%
540,686
-2.0%
1.18%
+20.2%
Q2 2019$17,154,000
+44.1%
551,921
+8.7%
0.98%
+22.5%
Q1 2019$11,902,000
+124.2%
507,564
+31.5%
0.80%
+86.5%
Q4 2018$5,309,000
+37.9%
385,8460.0%0.43%
+72.4%
Q3 2018$3,851,000
-48.3%
385,8460.0%0.25%
-54.7%
Q2 2018$7,455,000385,8460.55%
Other shareholders
EIDOS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Aisling Capital Management LP 1,123,630$56,777,00018.14%
Board of Trustees of The Leland Stanford Junior University 265,670$13,425,0005.17%
Opaleye Management Inc. 315,550$15,945,0003.12%
RA Capital Management 2,163,271$109,310,0002.00%
Cormorant Asset Management, LP 993,185$50,186,0001.93%
Parkman Healthcare Partners LLC 41,091$2,076,0000.55%
Perceptive Advisors 686,922$34,710,0000.51%
Redmile Group, LLC 466,205$23,557,0000.43%
Eventide Asset Management 317,417$16,039,0000.31%
Ikarian Capital, LLC 63,011$3,184,0000.23%
View complete list of EIDOS THERAPEUTICS INC shareholders